(-)-Lariciresinol

(-)-Lariciresinol
Product Name (-)-Lariciresinol
CAS No.: 83327-19-9
Catalog No.: CFN92501
Molecular Formula: C20H24O6
Molecular Weight: 360.4 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Targets: VEGFR
Source: The roots of Syringa oblata Lindl.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Lariciresinol administration can inhibit the tumor growth and tumor angiogenesis, conceivable importance of dietary lignan lariciresinol in inhibition of breast cancer development.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Talanta.2022, 249:123645.
  • Int. Conference on Med. Sci. and Bio.2017, 17973
  • Sci Rep. 2018, 1-9
  • Cancers (Basel).2021, 13(6):1432.
  • Journal of Functional Foods2017, 30:30-38
  • Plants2022, 11(3),294.
  • Pharm Biol.2017, 55(1):360-366
  • Biomed Pharmacother.2021, 139:111585.
  • SCOPUS.2020, 836-847.
  • J. Traditional Thai Medical Res. 2022,8(1):1-14.
  • Tortoside A

    Catalog No: CFN91784
    CAS No: 190655-16-4
    Price: $368/5mg
    Sanshodiol

    Catalog No: CFN96282
    CAS No: 54854-91-0
    Price: Inquiry(manager@chemfaces.com)
    (-)-Lariciresinol

    Catalog No: CFN92501
    CAS No: 83327-19-9
    Price: Inquiry(manager@chemfaces.com)
    Taxiresinol

    Catalog No: CFN97744
    CAS No: 40951-69-7
    Price: Inquiry(manager@chemfaces.com)
    Lariciresinol

    Catalog No: CFN98324
    CAS No: 27003-73-2
    Price: Inquiry(manager@chemfaces.com)
    Lariciresinol acetate

    Catalog No: CFN97679
    CAS No: 79114-77-5
    Price: Inquiry(manager@chemfaces.com)
    9-O-Feruloyllariciresinol

    Catalog No: CFN97023
    CAS No: 60337-67-9
    Price: Inquiry(manager@chemfaces.com)
    Lariciresinol 4'-O-glucoside

    Catalog No: CFN95400
    CAS No: 107110-16-7
    Price: $318/5mg
    Lariciresinol 4-O-glucoside

    Catalog No: CFN95389
    CAS No: 143663-00-7
    Price: $318/5mg
    Clemastanin B

    Catalog No: CFN95064
    CAS No: 112747-98-5
    Price: $298/10mg
    Int J Cancer. 2008 Sep 1;123(5):1196-204.
    Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.[Pubmed: 18528864 ]
    Lariciresinol is a dietary lignan that accounts for a significant portion of the total phytoestrogen intake from Western foods. Recent epidemiological studies suggest that high dietary intake of lignans and lariciresinol is associated with reduced breast cancer risk. However, no causal relationship between lariciresinol intake and breast cancer development has been established.
    METHODS AND RESULTS:
    In this study, we investigated for the first time the effects and possible mechanisms of action of lariciresinol on hormone responsive mammary cancer in vivo in dimethylbenz[a]anthracene induced mammary cancer in rats, and in human MCF-7 breast cancer xenografts in athymic mice. For tumor bearing rats, lariciresinol (3 or 15 mg/kg of body weight) or vehicle was administered p.o. daily for 9 weeks. For E2-maintained ovariectomized athymic mice bearing orthotopic MCF-7 tumors, control diet (AIN-93G) or lariciresinol containing diet (AIN-93G supplemented with 20 or 100 mg of lariciresinol/kg of diet) was administered for 5 weeks. In both models, lariciresinol administration inhibited the tumor growth and tumor angiogenesis. In MCF-7 cells, enterolactone significantly inhibited the E2-stimulated VEGF secretion. Moreover, in MCF-7 xenografts, lariciresinol administration enhanced tumor cell apoptosis and increased estrogen receptor beta expression. Lariciresinol and its further metabolites secoisolariciresinol, enterodiol and enterolactone were found in serum of both rats and athymic mice confirming a similar lignan metabolism pattern as in humans.
    CONCLUSIONS:
    These findings indicate conceivable importance of dietary lignan lariciresinol in inhibition of breast cancer development.
    FEBS Lett. 2007 Feb 20;581(4):603-10.
    (+)-Pinoresinol/(-)-lariciresinol reductase from Linum perenne Himmelszelt involved in the biosynthesis of justicidin B.[Pubmed: 17257599]

    METHODS AND RESULTS:
    A cDNA encoding a pinoresinol-lariciresinol reductase PLR (PLR-Lp1) was isolated from a cell culture of Linum perenne Himmelszelt accumulating the arylnaphthalene lignan justicidin B. The recombinant PLR-Lp1 prefers (+)-pinoresinol in the first reaction step, but (-)-Lariciresinol in the second step.
    CONCLUSIONS:
    Therefore, it is the first PLR described with opposite enantiospecificity within the two reaction steps catalysed by PLRs. Hairy root lines transformed with an ihpRNAi construct to suppress plr gene expression show less mRNA accumulation for the plr-Lp1 gene and PLR enzyme activity. Justicidin B accumulation was reduced down to 24% in comparison to control lines showing the involvement of PLR-Lp1 in the biosynthesis of justicidin B.
    Poricoic acid G

    Catalog No: CFN95056
    CAS No: 415724-84-4
    Price: $318/5mg
    Dehydrojuncusol

    Catalog No: CFN95143
    CAS No: 117824-04-1
    Price: $318/5mg
    Puerol B

    Catalog No: CFN95155
    CAS No: 112343-17-6
    Price: $398/5mg
    3-Hydroxy-4',5-dimethoxystilbene

    Catalog No: CFN95199
    CAS No: 58436-29-6
    Price: $318/10mg
    Stevia impurity (13-[(2-O-6-deoxy--D-glucopyranosyl-3-O--D-glucopyranosyl--D-glucopyranosyl)oxy]ent-kaur-16-en-19-oic acid -D-glucopyranosyl ester)

    Catalog No: CFN95229
    CAS No: 1309929-72-3
    Price: $463/5mg
    Isophysalin G

    Catalog No: CFN95328
    CAS No: 152221-21-1
    Price: $368/5mg
    Apigenin-8-C-beta-D-glucopyranosyl-6-C-[alpha-L-rhamnopyranosyl-(1->2)]-beta-glucopyranoside

    Catalog No: CFN95548
    CAS No: N/A
    Price: $368/5mg
    3',3'''-Binaringenin

    Catalog No: CFN95558
    CAS No: 145399-99-1
    Price: $413/5mg
    New compound 22

    Catalog No: CFN95570
    CAS No: N/A
    Price: $413/5mg
    Oxyphyllol B

    Catalog No: CFN95575
    CAS No: 226546-99-2
    Price: Inquiry(manager@chemfaces.com)